Nontuberculous Mycobacterial Pulmonary Disease: Clinical Epidemiologic Features, Risk Factors, and Diagnosis: The Nontuberculous Mycobacterial Series

Kartik Kumar; Michael R Loebinger

doi:10.1016/j.chest.2021.10.003

Nontuberculous Mycobacterial Pulmonary Disease: Clinical Epidemiologic Features, Risk Factors, and Diagnosis: The Nontuberculous Mycobacterial Series

Chest. 2022 Mar;161(3):637-646. doi: 10.1016/j.chest.2021.10.003. Epub 2021 Oct 8.

Authors

Kartik Kumar¹, Michael R Loebinger²

Affiliations

¹ National Heart and Lung Institute, Imperial College London, London, England; Host Defence Unit, Department of Respiratory Medicine, Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust, London, England.
² National Heart and Lung Institute, Imperial College London, London, England; Host Defence Unit, Department of Respiratory Medicine, Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust, London, England. Electronic address: m.loebinger@rbht.nhs.uk.

PMID: 34627854
DOI: 10.1016/j.chest.2021.10.003

Abstract

Nontuberculous mycobacterial pulmonary disease (NTM-PD) continues to impose a significant clinical burden of disease on susceptible patients. The incidence of NTM-PD is rising globally, but it remains a condition that is challenging to diagnose and treat effectively. This review provides an update on the global epidemiologic features, risk factors, and diagnostic considerations associated with the management of NTM-PD.

Keywords: epidemiology; microbiology; nontuberculous mycobacteria; radiology; risk factors.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Humans
Lung
Lung Diseases* / diagnosis
Lung Diseases* / epidemiology
Lung Diseases* / microbiology
Mycobacterium Infections, Nontuberculous* / diagnosis
Mycobacterium Infections, Nontuberculous* / epidemiology
Mycobacterium Infections, Nontuberculous* / microbiology
Nontuberculous Mycobacteria
Risk Factors